Furlanut M - Search Results

1

Prospectively validated dosing nomograms for maximizing the pharmacodynamics of vancomycin administered by continuous infusion in critically ill patients.

Pea F, Furlanut M, Negri C, Pavan F, Crapis M, Cristini F, Viale P. Pea F, et al. Among authors: furlanut m. Antimicrob Agents Chemother. 2009 May;53(5):1863-7. doi: 10.1128/AAC.01149-08. Epub 2009 Feb 17. Antimicrob Agents Chemother. 2009. PMID: 19223642 Free PMC article.

2

Antimicrobial agents in elective surgery: prophylaxis or "early therapy"?

Pea F, Viale P, Furlanut MI. Pea F, et al. Among authors: furlanut mi. J Chemother. 2003 Feb;15(1):3-11. doi: 10.1179/joc.2003.15.Supplement-2.3. J Chemother. 2003. PMID: 12678408 Review.

3

Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia.

Damiani D, Michieli M, Ermacora A, Russo D, Fanin R, Zaja F, Baraldo M, Pea F, Furlanut M, Baccarani M. Damiani D, et al. Among authors: furlanut m. Leukemia. 1998 Aug;12(8):1236-40. doi: 10.1038/sj.leu.2401092. Leukemia. 1998. PMID: 9697878 Clinical Trial.

4

Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients.

Pea F, Viale P, Cojutti P, Del Pin B, Zamparini E, Furlanut M. Pea F, et al. Among authors: furlanut m. J Antimicrob Chemother. 2012 Aug;67(8):2034-42. doi: 10.1093/jac/dks153. Epub 2012 May 2. J Antimicrob Chemother. 2012. PMID: 22553142

5

TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient.

Pea F, Cojutti P, Sbrojavacca R, Cadeo B, Cristini F, Bulfoni A, Furlanut M. Pea F, et al. Among authors: furlanut m. Ann Pharmacother. 2011 Jul;45(7-8):e37. doi: 10.1345/aph.1P745. Epub 2011 Jul 12. Ann Pharmacother. 2011. PMID: 21750307

6

What should be the first-choice strategy to maximize posaconazole exposure in daily clinical practice?

Pea F, Furlanut M, Viale P. Pea F, et al. Among authors: furlanut m. Antimicrob Agents Chemother. 2009 Aug;53(8):3608-9; author reply 609-10. doi: 10.1128/AAC.00256-09. Antimicrob Agents Chemother. 2009. PMID: 19617468 Free PMC article. No abstract available.

7

Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patients.

Pea F, Pavan F, Furlanut M. Pea F, et al. Among authors: furlanut m. Clin Pharmacokinet. 2008;47(7):449-62. doi: 10.2165/00003088-200847070-00002. Clin Pharmacokinet. 2008. PMID: 18563954 Review.

8

Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients.

Pea F, Tavio M, Pavan F, Londero A, Bresadola V, Adani GL, Furlanut M, Viale P. Pea F, et al. Among authors: furlanut m. Antivir Ther. 2008;13(5):739-42. Antivir Ther. 2008. PMID: 18771060

9

Biliary penetration and pharmacodynamic exposure of linezolid in liver transplant patients.

Pea F, Viale P, Lugano M, Baccarani U, Pavan F, Tavio M, Adani GL, Della Rocca G, Furlanut M. Pea F, et al. Among authors: furlanut m. J Antimicrob Chemother. 2009 Jan;63(1):167-9. doi: 10.1093/jac/dkn442. Epub 2008 Oct 24. J Antimicrob Chemother. 2009. PMID: 18952619

10

Educational and organizational interventions to improve the usefulness of clinical pharmacological advice for personalized drug dosing based on therapeutic drug monitoring.

Pea F, Dose L, Cojutti P, Baraldo M, Fontana F, Favaretti C, Furlanut M. Pea F, et al. Among authors: furlanut m. Basic Clin Pharmacol Toxicol. 2014 Nov;115(5):432-7. doi: 10.1111/bcpt.12249. Epub 2014 May 3. Basic Clin Pharmacol Toxicol. 2014. PMID: 24703163 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results